Affymax Articles
Takeda and Affymax recall all lots of anemia drug Omontys
25 February 2013
Affymax and Takeda get special Medicare code for Omontys
16 April 2012
Takeda to drop peginesatide commercialization in Japan
19 December 2011
FDA committee backs Affymax CKD drug
9 December 2011
US FDA sets PDUFA action dates for Bydureon and peginesatide
12 August 2011
Showing 1-12 of 12 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
